Eugene de Juan Jr., M.D.

Distinguished Professor of Ophthalmology, University of California, San Francisco
Managing Partner, ForSight Labs

Ophthalmology, Drug Delivery, Early Stage Company Development

EDUCATION
BS – Emory University
MS – University of Alabama in Birmingham
MD – University of South Alabama

AWARDS AND ACCOLADES
Lifetime Achievement Award: American Academy of Ophthalmology
Industry Innovator of the Year Award (OIS)
Catalyst Award: Glaucoma Research Foundation
Heed-Gutman Award: The Society of Heed Fellows

COMPANIES AND BOARDS
Co-Founder – Azura, Second Sight (NASDAQ:EYES), InnoRx (acquired by Surmodics), NeoVista (acquired by Orya), Retina Lab (acquired by Iridex), Transcend Medical (acquired by Novartis); ForSight VISION 1- 6; [ForSight VISION 2 (acquired by QLT), ForSight VISION 4 acquired by Genentech/Roche), ForSight VISION5 (acquired by Allergan)]

Board of Directors – Sprial Therapuetics, ForSight Vision 6, Presby, Voyant, Nexis Vision, Inc. (formerly ForSight VISION3)

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.